Eight biopharmaceutical and CXO companies on the Sci-Tech Innovation Board gathered for a performance briefing, breaking through key technological bottlenecks became the focus of interaction

On September 15th, a performance briefing for the sub-sectors of the Science and Technology Innovation Board was held, focusing on the biopharmaceutical and CXO industries. Eight companies, including Bide, CABIO, XuanTai Pharmaceutical, and Haohai Biological Technology, participated and responded to investor concerns through an online interactive Q&A format, clarifying the industry ecosystem and development trends. Journalists noted that amidst the rising prosperity of the biopharmaceutical industry, the R&D progress and global market layout of related companies have attracted significant attention. Thanks to high-intensity R&D investment, the participating companies are also full of confidence for the second half of the year